IGC

India全球化资本
AMEX

实时行情|Nasdaq Last Sale

0.6016
+0.0316
+5.54%
盘后: 0.6200 +0.0184 +3.06% 19:30 06/05 EDT
开盘
0.5800
昨收
0.5700
最高
0.6100
最低
0.5700
成交量
70.60万
成交额
--
52周最高
2.440
52周最低
0.2630
市值
2,365.50万
市盈率(TTM)
-4.1433
分时
5日
1月
3月
1年
5年

IGC 新闻

更多
India Globalization Capital, Inc. Announces Proposed Settlement of Three Derivative Lawsuits and Provides Notice to Shareholders
IGC announces today proposed settlement of three derivative lawsuits pending since 2018 & 2019 & provides notice to shareholders of the settlement.
Business Wire · 05/08 02:00
IGC nabs new patent in U.S.
seekingalpha · 03/27 15:48
IGC Receives New Patent from U.S. Patent Office to Treat Cachexia and Eating Disorders in Humans and Veterinary Animals
Business Wire · 03/27 01:30
IGC Reports Financial Results for the Quarter Ended December 31, 2019
Business Wire · 02/10 22:30
Comcast: 5%+ Correction Post Q4 Results Not Justified: Reiterate Buy
Seeking Alpha - Article · 01/24 20:48
Comcast -1.2% as UBS sees investments weighing growth
Seeking Alpha - Article · 01/24 14:30
Here are the biggest analyst calls of the day: Alphabet, Apple, PayPal, Intel & more
Here are the biggest calls on Wall Street on Friday
CNBC.com · 01/24 14:01
ClearBridge Multi Cap Growth Strategy Portfolio Manager Commentary Q4 2019
Seeking Alpha - Article · 01/24 12:35

所属板块

商业支持服务
+4.17%
专业与商业服务
+3.33%

热门股票

代码
价格
涨跌幅

IGC 简况

India Globalization Capital, Inc. develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States. The Company also builds farming facilities for leasing. In Malaysia, the Company develops and manages residential and commercial real estate. In India, it leases heavy equipment. It is also focused on developing, testing and patenting phytocannabinoid-based pharmaceutical therapies and becoming a specialty pharmaceutical provider of phytocannabinoid-based pharmaceutical and nutraceutical products. It is developing a product portfolio of phytocannabinoid-based therapies for indications, including neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis. In Malaysia, the Company’s subsidiary, Cabaran Ultima Sdn. Bhd., is focused on building a five-star hotel, Genting highlands.
展开

微牛提供India Globalization Capital, Inc.(AMEX-IGC)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的IGC股票新闻,以帮助您做出投资决策。